arrow
A

Aung Naing

investigational cancer therapeutics
H指数:74
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker study of pembrolizumab in patients with advanced rare cancers

帕博利珠单抗在晚期罕见癌症患者中的生物标志物研究

2026-06-160
OAAI
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson

在MD Anderson参与早期临床试验的晚期非小细胞肺癌患者中的治疗效果

2026-01-130
OAAI
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies

一项avelumab联合ivuxolimab、utomilumab和放射治疗的I/II期临床试验,用于治疗晚期胃肠道恶性肿瘤患者

2025-03-010
PRE
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (vol 40, pg 290, 2022)
2025-02-200
OAAI